Quarterly report pursuant to Section 13 or 15(d)

Stockholders??? Equity (Tables)

v3.20.2
Stockholders’ Equity (Tables)
9 Months Ended
Sep. 30, 2020
Stockholders' Equity Note [Abstract]
Schedule of fair value of options granted
Weighted Weighted
Average Average
Number of Exercise Remaining Intrinsic
Options Price Term (Yrs) Value
Outstanding, January 1, 2020 2,480,000 $ 4.34 9.86 $
-
Granted 200,000 2.15
Exercised
-
-
Expired
-
-
Forfeited (250,000 ) 4.47
Outstanding, September 30, 2020 2,430,000 $ 4.15 9.15 $
-
Exercisable, September 30, 2020 100,000 $ 5.66 2.38 $
-

Schedule of options outstanding and exercisable
Options Outstanding Options Exercisable
Weighted
Outstanding Average Exercisable
Exercise Number of Remaining Life Number of
Price Options In Years Options
$ 2.11 80,000
-
-
$ 2.17 120,000
-
-
$ 4.09 1,890,000
-
-
$ 5.66 340,000 2.38 100,000
2,430,000 100,000

Schedule of fair value of options granted
Risk free interest rate 0.55% – 0.69 %
Expected term (years) 6.25
Expected volatility 38 %
Expected dividends 0.00 %

Schedule of non-vested restricted stock activity
Number of
Restricted
Stock
Weighted
Average
Grant Date
Fair Value
Non-vested balance, January 1, 2020 80,393 $ 5.66
Granted 199,143 2.02
Vested (80,393 ) 5.66
Forfeited
-
-
Non-vested balance, September 30, 2020 199,143 $ 2.02

Schedule of warrant activity
Number of
Warrants
Weighted
Average
Exercise
Price
Weighted
Average
Remaining
Life in Years
Intrinsic
Value
Outstanding, January 1, 2020 18,637,003 $ 11.50 4.6 $
-
Issued 1,454,546 4.13
Exercised
-
-
Cancelled
-
-
Outstanding, September 30, 2020 20,091,549 $ 10.97 3.9 $
-
Exercisable, September 30, 2020 20,091,549 $ 10.97 3.9 $
-

Schedule of warrants outstanding and exercisable
Warrants Outstanding Warrants Exercisable
Exercise Price Exercisable Into Outstanding
Number of
Warrants
Weighted
Average
Remaining
Life in Years
Exercisable
Number of
Warrants
$ 11.50 Common Stock 18,637,003 3.9 18,637,003
$ 4.13 Common Stock 1,454,546 4.7 1,454,546
20,091,549 20,091,549